Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) EPS (Weighted Average and Diluted): 2022-2025

Historic EPS (Weighted Average and Diluted) for Roivant Sciences (ROIV) over the last 4 years, with Mar 2025 value amounting to -$0.75.

  • Roivant Sciences' EPS (Weighted Average and Diluted) rose 45.16% to -$0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.58, marking a year-over-year decrease of 110.53%. This contributed to the annual value of -$0.75 for FY2025, which is 113.37% down from last year.
  • According to the latest figures from FY2025, Roivant Sciences' EPS (Weighted Average and Diluted) is -$0.75, which was down 113.37% from $5.61 recorded in FY2024.
  • Roivant Sciences' EPS (Weighted Average and Diluted)'s 5-year high stood at $5.61 during FY2024, with a 5-year trough of -$1.42 in FY2023.
  • Its 3-year average for EPS (Weighted Average and Diluted) is $1.15, with a median of -$0.75 in 2025.
  • In the last 5 years, Roivant Sciences' EPS (Weighted Average and Diluted) surged by 495.07% in 2024 and then crashed by 113.37% in 2025.
  • Roivant Sciences' EPS (Weighted Average and Diluted) (Yearly) stood at -$1.26 in 2022, then decreased by 12.70% to -$1.42 in 2023, then soared by 495.07% to $5.61 in 2024, then plummeted by 113.37% to -$0.75 in 2025.